| A fasting inducible switch modulates gluconeogenesis via activator/coactivator exchange Y Liu, R Dentin, D Chen, S Hedrick, K Ravnskjaer, S Schenk, J Milne, ... Nature 456 (7219), 269-273, 2008 | 635 | 2008 |
| Class IIa histone deacetylases are hormone-activated regulators of FOXO and mammalian glucose homeostasis MM Mihaylova, DS Vasquez, K Ravnskjaer, PD Denechaud, TY Ruth, ... Cell 145 (4), 607-621, 2011 | 623 | 2011 |
| Cooperative interactions between CBP and TORC2 confer selectivity to CREB target gene expression K Ravnskjaer, H Kester, Y Liu, X Zhang, D Lee, JR Yates III, M Montminy The EMBO journal 26 (12), 2880-2889, 2007 | 201 | 2007 |
| Targeted disruption of the CREB coactivator Crtc2 increases insulin sensitivity Y Wang, H Inoue, K Ravnskjaer, K Viste, N Miller, Y Liu, S Hedrick, L Vera, ... Proceedings of the National Academy of Sciences 107 (7), 3087-3092, 2010 | 180 | 2010 |
| Peroxisome proliferator-activated receptor α (PPARα) potentiates, whereas PPARγ attenuates, glucose-stimulated insulin secretion in pancreatic β-cells K Ravnskjaer, M Boergesen, B Rubi, JK Larsen, T Nielsen, J Fridriksson, ... Endocrinology 146 (8), 3266-3276, 2005 | 131 | 2005 |
| Role of the cAMP pathway in glucose and lipid metabolism K Ravnskjaer, A Madiraju, M Montminy Metabolic Control, 29-49, 2016 | 129 | 2016 |
| PPARδ is a fatty acid sensor that enhances mitochondrial oxidation in insulin-secreting cells and protects against fatty acid-induced dysfunction K Ravnskjaer, F Frigerio, M Boergesen, T Nielsen, P Maechler, ... Journal of lipid research 51 (6), 1370-1379, 2010 | 113 | 2010 |
| Glucose-induced repression of PPARα gene expression in pancreatic β-cells involves PP2A activation and AMPK inactivation K Ravnskjaer, M Boergesen, LT Dalgaard, S Mandrup Journal of molecular endocrinology 36 (2), 289-299, 2006 | 109 | 2006 |
| Liver-fibrosis-activated transcriptional networks govern hepatocyte reprogramming and intra-hepatic communication A Loft, AJ Alfaro, SF Schmidt, FB Pedersen, MK Terkelsen, M Puglia, ... Cell metabolism 33 (8), 1685-1700. e9, 2021 | 107 | 2021 |
| Pancreatic β-cell lipotoxicity induced by overexpression of hormone-sensitive lipase M Sörhede Winzell, H Svensson, S Enerbäck, K Ravnskjaer, ... Diabetes 52 (8), 2057-2065, 2003 | 90 | 2003 |
| Glucagon regulates gluconeogenesis through KAT2B-and WDR5-mediated epigenetic effects K Ravnskjaer, MF Hogan, D Lackey, L Tora, SYR Dent, J Olefsky, ... The Journal of clinical investigation 123 (10), 4318-4328, 2013 | 88 | 2013 |
| Transcriptional regulation of Hepatic Stellate Cell activation in NASH AB Marcher, SM Bendixen, MK Terkelsen, SS Hohmann, MH Hansen, ... Scientific reports 9 (1), 2324, 2019 | 87 | 2019 |
| Transcriptional dynamics of hepatic sinusoid‐associated cells after liver injury MK Terkelsen, SM Bendixen, D Hansen, EAH Scott, AF Moeller, ... Hepatology 72 (6), 2119-2133, 2020 | 85 | 2020 |
| Peroxisome proliferator-activated receptor α (PPARα) protects against oleate-induced INS-1E beta cell dysfunction by preserving carbohydrate metabolism F Frigerio, T Brun, C Bartley, A Usardi, D Bosco, K Ravnskjaer, S Mandrup, ... Diabetologia 53, 331-340, 2010 | 51 | 2010 |
| Hepatic insulin resistance following chronic activation of the CREB coactivator CRTC2 MF Hogan, K Ravnskjaer, S Matsumura, MO Huising, RL Hull, SE Kahn, ... Journal of Biological Chemistry 290 (43), 25997-26006, 2015 | 36 | 2015 |
| The transcription factor ATF3 switches cell death from apoptosis to necroptosis in hepatic steatosis in male mice Y Inaba, E Hashiuchi, H Watanabe, K Kimura, Y Oshima, K Tsuchiya, ... Nature Communications 14 (1), 167, 2023 | 24 | 2023 |
| Circulating TREM2 as a noninvasive diagnostic biomarker for NASH in patients with elevated liver stiffness VI Chandran, CW Wernberg, MM Lauridsen, MK Skytthe, SM Bendixen, ... Hepatology 77 (2), 558-572, 2023 | 23 | 2023 |
| Functional genomics uncovers the transcription factor BNC2 as required for myofibroblastic activation in fibrosis M Bobowski-Gerard, C Boulet, FP Zummo, J Dubois-Chevalier, ... Nature Communications 13 (1), 5324, 2022 | 22 | 2022 |
| Osteoprotegerin is more than a possible serum marker in liver fibrosis: A study into its function in human and murine liver A Adhyatmika, L Beljaars, KSS Putri, H Habibie, CE Boorsma, ... Pharmaceutics 12 (5), 471, 2020 | 22 | 2020 |
| The role of diagnostic biomarkers, omics strategies, and single-cell sequencing for nonalcoholic fatty liver disease in severely obese patients CW Wernberg, K Ravnskjaer, MM Lauridsen, M Thiele Journal of Clinical Medicine 10 (5), 930, 2021 | 8 | 2021 |
